Latham & Watkins advised Seres Therapeutics, while Mayer Brown represented Société des Produits Nestlé on the deal. Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics...
Seres Therapeutics’ VOWST Asset Purchase Agreement With Nestlé Health Science
Nano Dimension’s Acquisition of Desktop Metal
Greenberg Traurig and Sullivan & Worcester are advising Nano Dimension, while Latham & Watkins and Shibolet & Co. are advising Desktop Metal on the deal. Nano...
TPG Capital’s Majority Investment in Confluent Medical Technologies
Latham & Watkins represented TPG Capital in the transaction. Confluent Medical Technologies (Confluent), a leading materials science, development, and manufacturing partner to medical device manufacturers, has...
P3 Health Partners’ Business Combination with Foresight Acquisition Corp.
Latham & Watkins represented P3 Health Partners in the transaction. P3 Health Partners, a patient-centered and physician-led population health management company, has closed its previously announced business combination...
Desktop Metal’s $575 Million Acquisition of ExOne
Latham & Watkins LLP represented Desktop Metal in the transaction. Desktop Metal, Inc. (NYSE: DM) and The ExOne Company (NASDAQ: XONE) have entered into a definitive...
The Topps Company’s $1.3 Billion Business Combination with Mudrick Capital Acquisition Corp.
Paul Hastings LLP advised Jefferies on the deal. Kirkland & Ellis advised The Topps Company, while Weil advised Mudrick Capital Acquisition Corporation II. Jefferies acted as...